Drug Patent Expirations for Mar 30, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SUMAVEL DOSEPRO (sumatriptan succinate) Endo Ventures Ltd Patent number: 6,280,410 Expiration Date: Mar 27, 2017 GEODON (ziprasidone mesylate) Pfizer Patent number: 6,232,304 Expiration Date: Apr 1, […]




Click here for reuse options!
Copyright 2017 Biotechblog

Drug Patent Expirations for Mar 23, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride) Osmotica Pharm Patent number: 6,403,120 Expiration Date: Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride) Osmotica Pharm Patent number: 6,419,958 Expiration Date: Mar […]




Click here for reuse options!
Copyright 2017 Biotechblog

Drug Patent Expirations for Mar 16, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. CHILDREN’S ALLEGRA ALLERGY (fexofenadine hydrochloride) Sanofi Aventis Us Patent number: 6,037,353 Expiration Date: Mar 14, 2017 CHILDREN’S ALLEGRA HIVES (fexofenadine hydrochloride) Sanofi Aventis Us Patent number: […]




Click here for reuse options!
Copyright 2017 Biotechblog

Drug Patent Expirations for Mar 9, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. EVISTA (raloxifene hydrochloride) Lilly Patent number: 6,458,811 Expiration Date: Mar 10, 2017 EVISTA (raloxifene hydrochloride) Lilly Patent number: 6,894,064 Expiration Date: Mar 10, 2017 EVISTA (raloxifene […]




Click here for reuse options!
Copyright 2017 Biotechblog

What is in licensing and out licensing in pharmaceutical sector?

These are relative terms. If I license a product from you, I am in-licensing it and you are out-licensing it. If I license a product to you, then I am out-licensing and you are in-licensing. See the full answer at quora




Click here for reuse options!
Copyright 2017 Biotechblog

3 Tips for Finding the Right Talent for Your Biotech Startup

This is a guest post from Steve Kirsh. Steve is Founder + Managing Partner of Khameleon Group. When was the last time you used a matchmaking service? Chances are it was today. Platforms like Amazon, Airbnb, eBay and Uber (as well as the proverbial dating sites) have transformed matchmaking into an everyday adventure in which […]




Click here for reuse options!
Copyright 2017 Biotechblog

Drug Patent Expirations for Feb 23, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. TAMIFLU (oseltamivir phosphate) Roche Patent number: 5,763,483 Expiration Date: Feb 23, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try […]




Click here for reuse options!
Copyright 2017 Biotechblog

Drug Patent Expirations for Feb 9, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZILECT (rasagiline mesylate) Teva Patent number: 5,453,446 Expiration Date: Feb 7, 2017 ELOXATIN (oxaliplatin) Sanofi Aventis Us Patent number: 5,420,319 Expiration Date: Feb 9, 2017 KYNAMRO […]




Click here for reuse options!
Copyright 2017 Biotechblog

Patent misuse in the Pharmaceutical sector

This is a guest post from Avneet Heer, a student in the MS Biotechnology BioBusiness Track at Georgetown University. Do you have a response to Avneet’s post? Respond in the comments section below. Politics, lobbying and monetary incentives have an increasing influence upon patent policy, especially drug patent policy. This has led to concerns over […]




Click here for reuse options!
Copyright 2017 Biotechblog

Biotech venture capital investments in public equities and performance

How do biotech venture investments in public equities (known as VIPEs) perform? Do they outperform mutual funds and hedge funds? While anecdotal evidence points to some really successful investments (e.g. Abingworth’s investment in Algeta in February 2009 (24x deal return)), this analysis of a large sample of VIPEs  in the biotechnology and pharmaceutical industry over […]




Click here for reuse options!
Copyright 2017 Biotechblog

%d bloggers like this: